Search Results 411-420 of 17887 for Coagulation

1. A Study to Compare CMP-001 Combined with Nivolumab to Nivolumab Alone in Advanced Melanoma Subjects - Mayo Clinic

   Coagulation: International normalized ratio or prothrombin time (PT) ≤ 1.5 × ULN, unless subject is receiving anticoagulant therapy, as long as PT or ...

2. A Study to Evaluate Feasibility of In Vivo Sensitivity Screen Using Direct Tumor Microinjection and FDG-PET in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer - Mayo Clinic

   Note: Heparin for line patency without detectable lab abnormalities for coagulation will be allowed. Participating Mayo Clinic locations. Study statuses ...

3. A Study to Assess the Safety, Tolerability and Effectiveness of LJN452 for Treating Patients who have Primary Biliary Cholangitis - Mayo Clinic

   ... coagulation disorders or screening blood tests that indicate altered coagulability (e.g. platelet count, aPTT, PTT or TT tests); History of conditions that ...

4. Coarctation of the aorta - Diagnosis and treatment - Mayo Clinic

   This heart condition is usually present at birth. It's treatable but requires lifelong health checkups. Learn about the causes and treatment.

5. Rotation Schedules - Curriculum - Mayo Clinic College of Medicine & Science

   Coagulation, 4 weeks. Blood and Marrow Transplant Inpatient Hospital Service, 4 weeks. Research, 2 weeks. Year 2. Rotation, Length. Hematology or Oncology ...

6. A Study to Compare A-CP HA Kit, Hyaluronic Acid and Placebo To Treatment Knee Osteoarthritis - Mayo Clinic

   Local infection in the affected knee -Hematologic or clotting disorders (thrombocytopenia) or blood coagulation (deficit-blood dyscrasia). Anaemia ...

7. Drugs and Supplements that Start with B - Mayo Clinic

   Coagulation factor ix recombinant (intravenous route). Benefix. Also known as. Factor ix (intravenous route, injection route). Benemid. Also known as.

8. Medical Laboratory Science Program (Florida and Minnesota) - Curriculum

   This course studies platelet function, coagulation factors, and acquired and hereditary hemorrhagic disorders. Laboratory techniques performed and discussed ...

9. Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions - Mayo Clinic

   Severely abnormal coagulation (INR>1.5); Patients with unstable cardiac status including: Unstable angina pectoris on medication; Patients with documented ...

10. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    Deep venous thrombosis within 6 months, unless the patient is anti-coagulated without the use of warfarin for at least 2 weeks. ... Patients who have been ...